D44N (p.Asp44Asn) variant of CD19 (B-lymphocyte antigen CD19)

D44N (p.Asp44Asn) in CD19 (B-lymphocyte antigen CD19) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.08 / 1. The record also includes population frequency data and structural context.

D44N (p.Asp44Asn) variant details